Molecular Breast Imaging Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2030

Description

Persistence Market Research has conducted a thorough analysis of the Molecular Breast Imaging Market, providing a comprehensive report detailing its global landscape. This in-depth publication offers valuable insights into the market's dynamics, trends, opportunities, and challenges, providing a comprehensive overview of its structure. Backed by exclusive data and statistics, the research predicts the anticipated growth trajectory of the Molecular Breast Imaging Market spanning from 2023 to 2030.

The worldwide molecular breast imaging market is projected to grow at a compound annual growth rate (CAGR) of 6.9%, reaching a value of US$1,246.6 million by the conclusion of 2030, up from US$781.4 million in 2023.

Key Insights:

Molecular Breast Imaging Market Size (2023E): US$781.4 Mn
Projected Market Value (2030F): US$1,246.6 Mn
Global Market Growth Rate (CAGR 2023 to 2030): 6.9%
Historical Market Growth Rate (CAGR 2018 to 2022): 6.1%

Molecular Breast Imaging Market - Report Scope

Molecular breast imaging (MBI) is a specialized technique for diagnosing breast cancer, employing a radioactive tracer and gamma camera to detect cellular activity in breast tissues. It offers enhanced accuracy, particularly for women with dense breast tissue. The market is growing due to increased breast cancer incidence, technological advancements, and improved patient outcomes associated with MBI.

Market Growth Drivers

Advancements in imaging technology are driving the molecular breast imaging market, with increasingly sophisticated MBI systems offering better sensitivity and resolution. These innovations, including digital detectors and advanced algorithms, enhance early cancer detection and overcome challenges posed by dense breast tissue. Additionally, the growing focus on personalized medicine is boosting MBI adoption, as it provides precise assessments for tailored treatment plans, aligning with the trend towards individualized healthcare solutions.

Market Restraints

Compliance, safety, budgetary limitations, and accessibility hurdles pose challenges for the molecular breast imaging market. Regulatory obstacles, radiation concerns, high costs, and uneven facility distribution hinder widespread adoption. Solutions require constant innovation, strict safety measures, strategic pricing, partnerships, and creative funding approaches.

Opportunities

Expanding the applications of molecular breast imaging beyond breast cancer screening opens new opportunities for the market. Research and development efforts could explore its potential in detecting various malignancies or medical conditions as they develop, extending its diagnostic capabilities beyond breast tissue. This diversification enables medical imaging manufacturers to tap into new markets and broaden their offerings. Furthermore, the integration of Artificial Intelligence (AI) with molecular breast imaging enhances diagnostic accuracy and efficiency. AI systems can quickly analyze MBI images, aiding in the detection of subtle abnormalities and accelerating diagnosis. Collaboration between MBI manufacturers and AI technology developers fosters the creation of intelligent diagnostic tools, improving patient outcomes and positioning businesses at the forefront of advanced imaging technology.

Key Questions Answered in Report::

What is the current market size and forecast for the molecular breast imaging industry?
What are the main drivers propelling the growth of the molecular breast imaging market?
What are the major challenges and obstacles faced by the molecular breast imaging industry?
What are the regulatory considerations and safety concerns associated with molecular breast imaging?
How do budgetary limitations and accessibility issues impact the adoption of molecular breast imaging technology?

Competitive Intelligence and Business Strategy

The Molecular Breast Imaging (MBI) market is fiercely competitive, driven by strategic partnerships, technological advancements, and mergers and acquisitions. Leading players invest heavily in R&D to develop cutting-edge MBI systems, while alliances with academic and healthcare institutions ensure clinical validation and innovation. The emphasis on scalable and affordable solutions enhances accessibility across healthcare providers, shaping the dynamic competitive landscape of the industry.

Key Companies Profiled

Koninklijke Philips N.V. (Netherlands)
Hitachi Ltd. (Japan)
Siemens Healthcare GmbH (Germany)
CANON MEDICAL SYSTEMS CORPORATION (Japan)
General Electric (US)
Aspect Imaging Ltd (Israel)
Bruker (US),
Aurora Health Care (US)
FONAR Corp. (US)
ESAOTE SPA (Italy)
Neusoft Corporation (China)
TOSHIBA CORPORATION (Japan)

Molecular Breast Imaging Market Segmentation

By Modality:

Single Head Gamma Camera
Dual Head Camera

By Imaging Technique:

Planar Imaging
SPECT Imaging

By Application:

Screening
Diagnosis
Others (such as research and development)

By End User:

Hospital
Diagnostic Imaging Centers
Breast Cancer Care

By Region:

North America
Europe
East Asia
South Asia & Oceania
Latin America
Middle East & Africa

Product Code: PMRREP33944

1. Executive Summary

1.1. Global Molecular Breast Imaging Market Snapshot, 2023 and 2030
1.2. Market Opportunity Assessment, 2023 - 2030, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations

2. Market Overview

2.1. Market Scope and Definition
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Opportunity
- 2.2.4. Challenges
- 2.2.5. Key Trends
2.3. Modality Lifecycle Analysis
2.4. Molecular Breast Imaging Market: Value Chain
- 2.4.1. List of Raw Material Supplier
- 2.4.2. List of Manufacturers
- 2.4.3. List of Distributors
- 2.4.4. List of Applications
- 2.4.5. Profitability Analysis
2.5. Porter Five Force's Analysis
2.6. Geopolitical Tensions: Market Impact
2.7. Macro-Economic Factors
- 2.7.1. Global Sectorial Outlook
- 2.7.2. Global GDP Growth Outlook
- 2.7.3. Global Parent Market Overview
2.8. Forecast Factors - Relevance and Impact
2.9. Regulatory and Technology Landscape

3. Global Molecular Breast Imaging Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

3.1. Key Highlights
- 3.1.1. Market Volume (Units) Projections
- 3.1.2. Market Size and Y-o-Y Growth
- 3.1.3. Absolute $ Opportunity
3.2. Market Size (US$ Mn) Analysis and Forecast
- 3.2.1. Historical Market Size Analysis, 2013-2016
- 3.2.2. Current Market Size Forecast, 2018-2026
3.3. Global Molecular Breast Imaging Market Outlook: Modality
- 3.3.1. Introduction / Key Findings
- 3.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Modality, 2018 - 2022
- 3.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Modality, 2023 - 2030
  - 3.3.3.1. Single Head Gamma Camera
  - 3.3.3.2. Dual Head Camera
3.4. Market Attractiveness Analysis: Modality
3.5. Global Molecular Breast Imaging Market Outlook: Imaging Technique
- 3.5.1. Introduction / Key Findings
- 3.5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Imaging Technique, 2018 - 2022
- 3.5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Imaging Technique, 2023 - 2030
  - 3.5.3.1. Planar Imaging
  - 3.5.3.2. SPECT Imaging
3.6. Market Attractiveness Analysis: Imaging Technique
3.7. Global Molecular Breast Imaging Market Outlook: Application
- 3.7.1. Introduction / Key Findings
- 3.7.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Application, 2018 - 2022
- 3.7.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
  - 3.7.3.1. Screening
  - 3.7.3.2. Diagnosis
  - 3.7.3.3. Others (such as research and development)
  - 3.7.3.4. Misc
3.8. Market Attractiveness Analysis: Application
3.9. Global Molecular Breast Imaging Market Outlook: End User
- 3.9.1. Introduction / Key Findings
- 3.9.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By End User, 2018 - 2022
- 3.9.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
  - 3.9.3.1. Hospital
  - 3.9.3.2. Diagnostic Imaging Centers
  - 3.9.3.3. Breast Cancer Care
3.10. Market Attractiveness Analysis: End User

4. Global Molecular Breast Imaging Market Outlook: Region

4.1. Key Highlights
4.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2018 - 2022
4.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2023 - 2030
- 4.3.1. North America
- 4.3.2. Europe
- 4.3.3. East Asia
- 4.3.4. South Asia and Oceania
- 4.3.5. Latin America
- 4.3.6. Middle East & Africa (MEA)
4.4. Market Attractiveness Analysis: Region

5. North America Molecular Breast Imaging Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

5.1. Key Highlights
5.2. Pricing Analysis
5.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 5.3.1. By Country
- 5.3.2. By Modality
- 5.3.3. By Imaging Technique
- 5.3.4. By Application
- 5.3.5. By End User
5.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 5.4.1. U.S.
- 5.4.2. Canada
5.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Modality, 2023 - 2030
- 5.5.1. Single Head Gamma Camera
- 5.5.2. Dual Head Camera
5.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Imaging Technique, 2023 - 2030
- 5.6.1. Planar Imaging
- 5.6.2. SPECT Imaging
- 5.6.3. Hardware
5.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
- 5.7.1. Screening
- 5.7.2. Diagnosis
- 5.7.3. Others (such as research and development)
5.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
- 5.8.1. Hospital
- 5.8.2. Diagnostic Imaging Centers
- 5.8.3. Breast Cancer Care
5.9. Market Attractiveness Analysis

6. Europe Molecular Breast Imaging Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

6.1. Key Highlights
6.2. Pricing Analysis
6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 6.3.1. By Country
- 6.3.2. By Modality
- 6.3.3. By Imaging Technique
- 6.3.4. By Application
- 6.3.5. By End User
6.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 6.4.1. Germany
- 6.4.2. France
- 6.4.3. U.K.
- 6.4.4. Italy
- 6.4.5. Spain
- 6.4.6. Russia
- 6.4.7. Turkiye
- 6.4.8. Rest of Europe
6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Modality, 2023 - 2030
- 6.5.1. Single Head Gamma Camera
- 6.5.2. Dual Head Camera
6.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Imaging Technique, 2023 - 2030
- 6.6.1. Planar Imaging
- 6.6.2. SPECT Imaging
6.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
- 6.7.1. Screening
- 6.7.2. Diagnosis
- 6.7.3. Others (such as research and development)
6.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
- 6.8.1. Hospital
- 6.8.2. Diagnostic Imaging Centers
- 6.8.3. Breast Cancer Care
6.9. Market Attractiveness Analysis

7. East Asia Molecular Breast Imaging Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

7.1. Key Highlights
7.2. Pricing Analysis
7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 7.3.1. By Country
- 7.3.2. By Modality
- 7.3.3. By Imaging Technique
- 7.3.4. By Application
- 7.3.5. By End User
7.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 7.4.1. China
- 7.4.2. Japan
- 7.4.3. South Korea
7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Modality, 2023 - 2030
- 7.5.1. Single Head Gamma Camera
- 7.5.2. Dual Head Camera
7.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Imaging Technique, 2023 - 2030
- 7.6.1. Planar Imaging
- 7.6.2. SPECT Imaging
7.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
- 7.7.1. Screening
- 7.7.2. Diagnosis
- 7.7.3. Others (such as research and development)
7.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
- 7.8.1. Hospital
- 7.8.2. Diagnostic Imaging Centers
- 7.8.3. Breast Cancer Care
7.9. Market Attractiveness Analysis

8. South Asia & Oceania Molecular Breast Imaging Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

8.1. Key Highlights
8.2. Pricing Analysis
8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 8.3.1. By Country
- 8.3.2. By Modality
- 8.3.3. By Imaging Technique
- 8.3.4. By Application
- 8.3.5. By End User
8.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 8.4.1. India
- 8.4.2. Southeast Asia
- 8.4.3. ANZ
- 8.4.4. Rest of South Asia & Oceania
8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Modality, 2023 - 2030
- 8.5.1. Single Head Gamma Camera
- 8.5.2. Dual Head Camera
8.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Imaging Technique, 2023 - 2030
- 8.6.1. Planar Imaging
- 8.6.2. SPECT Imaging
8.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
- 8.7.1. Screening
- 8.7.2. Diagnosis
- 8.7.3. Others (such as research and development)
8.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
- 8.8.1. Hospital
- 8.8.2. Diagnostic Imaging Centers
- 8.8.3. Breast Cancer Care
8.9. Market Attractiveness Analysis

9. Latin America Molecular Breast Imaging Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

9.1. Key Highlights
9.2. Pricing Analysis
9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 9.3.1. By Country
- 9.3.2. By Modality
- 9.3.3. By Imaging Technique
- 9.3.4. By Application
- 9.3.5. By End User
9.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 9.4.1. Brazil
- 9.4.2. Mexico
- 9.4.3. Rest of Latin America
9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Modality, 2023 - 2030
- 9.5.1. Single Head Gamma Camera
- 9.5.2. Dual Head Camera
9.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Imaging Technique, 2023 - 2030
- 9.6.1. Planar Imaging
- 9.6.2. SPECT Imaging
9.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
- 9.7.1. Screening
- 9.7.2. Diagnosis
- 9.7.3. Others (such as research and development)
9.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
- 9.8.1. Hospital
- 9.8.2. Diagnostic Imaging Centers
- 9.8.3. Breast Cancer Care
9.9. Market Attractiveness Analysis

10. Middle East & Africa Molecular Breast Imaging Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

10.1. Key Highlights
10.2. Pricing Analysis
10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 10.3.1. By Country
- 10.3.2. By Modality
- 10.3.3. By Imaging Technique
- 10.3.4. By Application
- 10.3.5. By End User
10.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 10.4.1. GCC
- 10.4.2. Egypt
- 10.4.3. South Africa
- 10.4.4. Northern Africa
- 10.4.5. Rest of Middle East & Africa
10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Modality, 2023 - 2030
- 10.5.1. Single Head Gamma Camera
- 10.5.2. Dual Head Camera
10.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Imaging Technique, 2023 - 2030
- 10.6.1. Planar Imaging
- 10.6.2. SPECT Imaging
10.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
- 10.7.1. Screening
- 10.7.2. Diagnosis
- 10.7.3. Others (such as research and development)
10.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
- 10.8.1. Hospital
- 10.8.2. Diagnostic Imaging Centers
- 10.8.3. Breast Cancer Care
10.9. Market Attractiveness Analysis

11. Competition Landscape

11.1. Market Share Analysis, 2022
11.2. Market Structure
- 11.2.1. Competition Intensity Mapping By Market
- 11.2.2. Competition Dual Head Camera
- 11.2.3. Apparent Product Capacity
11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
- 11.3.1. Koninklijke Philips N.V. (Netherlands)
  - 11.3.1.1. Overview
  - 11.3.1.2. Segments and Product
  - 11.3.1.3. Key Financials
  - 11.3.1.4. Market Developments
  - 11.3.1.5. Market Strategy
- 11.3.2. Hitachi Ltd. (Japan)
  - 11.3.2.1. Overview
  - 11.3.2.2. Segments and Product
  - 11.3.2.3. Key Financials
  - 11.3.2.4. Market Developments
  - 11.3.2.5. Market Strategy
- 11.3.3. Siemens Healthcare GmbH (Germany)
  - 11.3.3.1. Overview
  - 11.3.3.2. Segments and Product
  - 11.3.3.3. Key Financials
  - 11.3.3.4. Market Developments
  - 11.3.3.5. Market Strategy
- 11.3.4. CANON MEDICAL SYSTEMS CORPORATION (Japan)
  - 11.3.4.1. Overview
  - 11.3.4.2. Segments and Product
  - 11.3.4.3. Key Financials
  - 11.3.4.4. Market Developments
  - 11.3.4.5. Market Strategy
- 11.3.5. General Electric (US)
  - 11.3.5.1. Overview
  - 11.3.5.2. Segments and Product
  - 11.3.5.3. Key Financials
  - 11.3.5.4. Market Developments
  - 11.3.5.5. Market Strategy
- 11.3.6. Aspect Imaging Ltd (Israel)
  - 11.3.6.1. Overview
  - 11.3.6.2. Segments and Product
  - 11.3.6.3. Key Financials
  - 11.3.6.4. Market Developments
  - 11.3.6.5. Market Strategy
- 11.3.7. Bruker (US),
  - 11.3.7.1. Overview
  - 11.3.7.2. Segments and Product
  - 11.3.7.3. Key Financials
  - 11.3.7.4. Market Developments
  - 11.3.7.5. Market Strategy
- 11.3.8. Aurora Health Care (US)
  - 11.3.8.1. Overview
  - 11.3.8.2. Segments and Product
  - 11.3.8.3. Key Financials
  - 11.3.8.4. Market Developments
  - 11.3.8.5. Market Strategy
- 11.3.9. FONAR Corp. (US)
  - 11.3.9.1. Overview
  - 11.3.9.2. Segments and Product
  - 11.3.9.3. Key Financials
  - 11.3.9.4. Market Developments
  - 11.3.9.5. Market Strategy
- 11.3.10. ESAOTE SPA (Italy)
  - 11.3.10.1. Overview
  - 11.3.10.2. Segments and Product
  - 11.3.10.3. Key Financials
  - 11.3.10.4. Market Developments
  - 11.3.10.5. Market Strategy
- 11.3.11. Neusoft Corporation (China)
  - 11.3.11.1. Overview
  - 11.3.11.2. Segments and Product
  - 11.3.11.3. Key Financials
  - 11.3.11.4. Market Developments
  - 11.3.11.5. Market Strategy
- 11.3.12. TOSHIBA CORPORATION (Japan)
  - 11.3.12.1. Overview
  - 11.3.12.2. Segments and Product
  - 11.3.12.3. Key Financials
  - 11.3.12.4. Market Developments
  - 11.3.12.5. Market Strategy

12. Appendix

12.1. Research Methodology
12.2. Research Assumptions
12.3. Acronyms and Abbreviations